A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents

by R. Ke, J.M. Conway, A.S. Perelson
Published 2015-12-01

Constraints on the dynamics of HIV-1 lifecycle elucidated by treatment with an integrase inhibitor reveal a subset of cells with very slow integration

by R.M. Ribeiro, F. Cardozo, A.S. Perelson
Published 2015-12-01

Sustained HIV release by single persisting CD4+ T cells during latency disruption

by J.M. Hataye, J.P. Casazza, D.R. Ambrozak, E. Boritz, T. Yamamoto, D.C. Douek, A.S. Perelson, R.A. Koup
Published 2015-12-01